153 related articles for article (PubMed ID: 11222361)
21. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
22. Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.
Okabe-Kado J; Kasukabe T; Honma Y
Leuk Lymphoma; 1998 Dec; 32(1-2):19-28. PubMed ID: 10036998
[TBL] [Abstract][Full Text] [Related]
23. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
24. nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas.
Lee JH; Cho SJ; Zhang X; Zheng Z; Lee ES; Kim A; Kim YS; Chae YS; Kim I
J Korean Med Sci; 2006 Aug; 21(4):645-51. PubMed ID: 16891807
[TBL] [Abstract][Full Text] [Related]
25. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.
Müller W; Schneiders A; Hommel G; Gabbert HE
Cancer; 1998 Dec; 83(12):2481-7. PubMed ID: 9874452
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
Lai WW; Wu MH; Yan JJ; Chen FF
Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
[TBL] [Abstract][Full Text] [Related]
27. High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance.
Aryee DN; Ströbel T; Kos K; Salzer-Kuntschik M; Zoubek A; Veron M; Ambros IM; Traincart F; Gadner H; Kovar H
Int J Cancer; 1995 Apr; 64(2):104-11. PubMed ID: 7542225
[TBL] [Abstract][Full Text] [Related]
28. The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified.
Niitsu N
J Clin Exp Hematop; 2014; 54(3):171-7. PubMed ID: 25501107
[TBL] [Abstract][Full Text] [Related]
29. nm23-H1 expression in nasopharyngeal carcinoma: correlation with clinical outcome.
Guo X; Min HQ; Zeng MS; Qian CN; Huang XM; Shao JY; Hou JH
Int J Cancer; 1998 Dec; 79(6):596-600. PubMed ID: 9842967
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma.
Yoo CH; Noh SH; Kim H; Lee HY; Min JS
J Surg Oncol; 1999 May; 71(1):22-8. PubMed ID: 10362087
[TBL] [Abstract][Full Text] [Related]
32. The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma.
Iizuka N; Tangoku A; Hayashi H; Yosino S; Abe T; Morioka T; Oka M
Cancer Lett; 1999 Apr; 138(1-2):139-44. PubMed ID: 10378785
[TBL] [Abstract][Full Text] [Related]
33. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
[TBL] [Abstract][Full Text] [Related]
34. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
[TBL] [Abstract][Full Text] [Related]
35. Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis.
Pavelić K; Kapitanović S; Radosević S; Bura M; Seiwerth S; Pavelić LJ; Unusić J; Spaventi R
J Mol Med (Berl); 2000; 78(2):111-8. PubMed ID: 10794547
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
[TBL] [Abstract][Full Text] [Related]
37. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
[TBL] [Abstract][Full Text] [Related]
38. Reappraisal of the role of NM23-H1 in colorectal cancers.
Lee JC; Lin YJ; Chow NH; Wang ST
J Surg Oncol; 2001 Jan; 76(1):58-62. PubMed ID: 11223826
[TBL] [Abstract][Full Text] [Related]
39. [Expression of CD44V6 and nm23-H1 in thyroid papillary adenocarcinoma and lymph node metastasis].
Wei Q; Fan S
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):5-7, 30. PubMed ID: 10681781
[TBL] [Abstract][Full Text] [Related]
40. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]